LONDON, Oct. 29, 2014 /PRNewswire/ -- Needle-free drug delivery devices are novel techniques to introduce drugs into patient's body without invading the skin with a conventional needle. This technology provides effective drug delivery for wide range of drugs; it is bioequivalent to syringe and needle and results in less pain. This report studies the current scenario as well as the future market potential for needle-free drug delivery devices globally. The needle-free drug delivery devices market has been segmented in two major segments, on the basis of technology and applications. Needle-free drug delivery devices market by technology is sub segmented as jet injectors and competing needle-free technologies. Further, competing needle-free technologies are divided into novel needle technology, inhaler technology and transdermal patch delivery. Needle-free drug delivery device market by applications is further segmented as, vaccine delivery (developing immune response), pain management, insulin delivery for diabetes, pediatric injections and other classes. The market for these devices has been extensively analyzed on the basis of factors such as patient compliance and acceptability, increased utility of needle-free devices in various kinds of diseases, opportunities for development of home-care and self medication devices and others. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2013 to 2019, considering 2012 as the base year. The needle-free drug delivery devices market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.
continue here
continue here
No comments:
Post a Comment